Author:
Gardner J. D.,Perdomo C.,Sloan S.,Hahne W. F.,Barth J. A.,Rodriguez-Stanley S.,Robinson M.
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Reference25 articles.
1. Day-to-day variation of 24-hour intragastric acidity;Merki;Gastroenterology,1988
2. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility;Jamieson;Am J Gastroenterol,1992
3. 24-h pH monitoring for gastroesophageal reflux disease: already standard but not yet gold?;Quigley;Am J Gastroenterol,1992
4. Appropriate acid suppression for the management of gastroesophageal reflux disease;Bell;Digestion,1992
5. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers;Bruley des Varannes;Aliment Pharmacol Ther,1994
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GASTRIC ACIDITY IN DIFFERENT PHENOTYPES OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE;2023-04-17
2. Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects;Drug Design, Development and Therapy;2023-04
3. Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole;Drug Design, Development and Therapy;2023-02
4. Pharmacokinetics and Pharmacodynamics of YYD601, a Dual Delayed-Release Formulation of Esomeprazole, Following Single and Multiple Doses in Healthy Adult Volunteers Under Fasting and Fed Conditions;Drug Design, Development and Therapy;2022-03
5. The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
;Drug Design, Development and Therapy;2019-09